InVivo Therapeutics Corp Beta
Was ist das Beta von InVivo Therapeutics Corp?
Beta von InVivo Therapeutics Holdings Corp ist 1.07
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu InVivo Therapeutics Corp
Was macht InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Unternehmen mit beta ähnlich InVivo Therapeutics Corp
- Nitto Denko hat Beta von 1.07
- Minerals Technologies hat Beta von 1.07
- Asia Orient hat Beta von 1.07
- China Aerospace International hat Beta von 1.07
- Umang Dairies hat Beta von 1.07
- Umicore hat Beta von 1.07
- InVivo Therapeutics Corp hat Beta von 1.07
- Playgon Games hat Beta von 1.07
- First Merchants hat Beta von 1.07
- Audinate hat Beta von 1.07
- Funtastic hat Beta von 1.07
- Canasil Resources hat Beta von 1.07
- Wuxi Biologics (Cayman) hat Beta von 1.07